Tissue Engineering
Biological materials for tissue engineering and regenerative medicine — from FBS Low Endotoxin for primary cell culture through human platelet lysate for GMP MSC expansion to recombinant HSA for defined scaffold-based media. Supporting cartilage, bone, cardiac, vascular and neural tissue engineering workflows.
Product Selection for Tissue Engineering
| TE Application | Recommended Product | Key Reason |
|---|---|---|
| Chondrocyte culture (cartilage TE) | FBS Low Endotoxin ≤5 EU/mL | Eliminates NF-κB-mediated MMP upregulation that degrades collagen II and aggrecan |
| Osteoblast / bone marrow MSC culture | FBS Low Endotoxin or hPL | Low endotoxin for mineralisation; hPL for xeno-free GMP protocols |
| MSC expansion — research | FBS Standard or Low Endotoxin | Cost-effective; 10% FBS standard for MSC expansion at research scale |
| MSC expansion — GMP / clinical | Human Platelet Lysate (hPL) | Xeno-free; 3–5× higher proliferation; ISO 13485 documentation |
| Scaffold-based TE (defined medium) | rHSA Premium + growth factors | Chemically defined protein scaffold — eliminates FBS lot variability in 3D culture |
| Cardiac / cardiomyocyte culture | FBS Low Endotoxin + HSA | Endotoxin suppresses cardiomyocyte differentiation markers |
| Endothelial cell / vascular TE | FBS Low Endotoxin | Endothelial cells sensitive to LPS-induced inflammatory activation |
| Neural TE / neurosphere culture | Serum-free + rHSA or hPL | Serum causes glial differentiation in neural stem cells — defined or xeno-free preferred |
| Organoid — intestinal / hepatic | OrganoMedium or Serum-Free + rHSA | Defined serum-free eliminates organoid morphology variability from serum lots |
Why Endotoxin Matters in Tissue Engineering
Standard cell culture FBS (up to 50 EU/mL endotoxin) is well-tolerated by immortalised cell lines such as CHO or HEK293 that have reduced TLR4 signalling. Primary cells used in tissue engineering retain full innate immune sensitivity — and endotoxin-induced NF-κB activation directly antagonises tissue-specific differentiation programmes.
Chondrocytes: Endotoxin upregulates MMP-3 and MMP-13 (matrix metalloproteinases) that degrade collagen II and aggrecan — exactly the matrix components the chondrocyte needs to produce for cartilage formation.
Osteoblasts: LPS inhibits mineralisation and osteocalcin expression through TNF-α upregulation.
Endothelial cells: Endotoxin induces ICAM-1 and E-selectin expression, shifts cells to inflammatory phenotype and disrupts tube formation assays.
FBS Endotoxin Levels Compared
| Grade | Endotoxin | TE Suitability |
|---|---|---|
| FBS Standard | ≤10 EU/mL | Not recommended for primary TE cells |
| FBS Low Endotoxin | ≤5 EU/mL | Suitable for most primary TE cells |
| FBS Ultra-Low Endotoxin | ≤1 EU/mL | Highly sensitive primary cells, neuronal |
| FBS ES Cell Pre-Tested | ≤1 EU/mL | Stem cell-derived TE applications |
Key Products for Tissue Engineering
FBS Low Endotoxin
≤5 EU/mL. Standard for primary cell TE culture — chondrocytes, osteoblasts, endothelial cells, cardiomyocytes. Multiple origins including Australian.
Human Platelet Lysate (hPL)
Freeze-thaw lysed human platelets — maximum growth factors, xeno-free, GMP-compatible. The standard FBS replacement for GMP MSC expansion. 3–5× higher proliferation than FBS.
rHSA Premium Grade
4–8 g/L in scaffold-based TE medium as xeno-free protein supplement. Chemically defined, no lot variability. ISO 13485 documentation for regulatory files.
OrganoMedium
Defined serum-free medium for intestinal, hepatic and neural organoid culture — eliminates serum lot variability in 3D scaffold and suspension organoid culture.
HSA Cell Culture Grade
For xeno-free TE media supplementation, cryoprotection of TE constructs and clinical-stage scaffold manufacturing.
FBS ES Cell Pre-Tested
Qualified for stem cell maintenance and stem cell-derived TE applications. Lot-tested for pluripotency maintenance and directed differentiation support.
More Frequently Asked Questions
Why is FBS Low Endotoxin specifically required for tissue engineering with primary cells?
Primary cells — chondrocytes, osteoblasts, endothelial cells, cardiomyocytes — retain full TLR4 innate immune sensitivity. Endotoxin at 5–50 EU/mL in standard FBS activates NF-κB-mediated inflammatory gene expression that antagonises the differentiation programme. In chondrocytes, this upregulates MMP-3/MMP-13 and suppresses collagen II and aggrecan — exactly the ECM components needed for cartilage TE. FBS Low Endotoxin (≤5 EU/mL) eliminates this interference.
When should hPL replace FBS for MSC expansion in tissue engineering?
hPL is preferred when the application targets clinical translation or GMP-adjacent manufacturing (xeno-free required), when higher MSC proliferation is needed (hPL achieves 3–5× more than FBS), or when FBS lot variability is causing reproducibility issues. hPL requires its own lot qualification. SeamlessBio hPL is from pooled EU donors with full pathogen screening and ISO 13485 documentation.
Can rHSA be used as a serum substitute in scaffold-based TE medium?
rHSA Premium Grade at 4–8 g/L combined with defined growth factors (ITS, EGF, FGF-2 per cell type) replaces FBS as the protein supplement in scaffold-based TE medium. This provides a xeno-free, chemically defined matrix for GMP-adjacent TE — without the undefined growth factor variability that makes lot-to-lot validation difficult in scaffold culture.
Request TE Samples & Lot Reservation
Free test samples of FBS Low Endotoxin, hPL and rHSA. Lot reservation without prepayment. Full documentation per lot.
English 
Deutsch